Holen Sie sich die Stockscreener-App
2.78
4.79%
-0.14
Handel nachbörslich:
2.75
-0.03
-1.08%
Schlusskurs vom Vortag:
$2.92
Offen:
$2.93
24-Stunden-Volumen:
75,212
Relative Volume:
0.30
Marktkapitalisierung:
$3.67M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.42M
KGV:
-0.0356
EPS:
-78
Netto-Cashflow:
$-16.67M
1W Leistung:
-35.65%
1M Leistung:
-74.73%
6M Leistung:
-81.77%
1J Leistung:
-95.76%
1-Tages-Spanne:
$2.71
$3.05
1-Wochen-Bereich:
$2.71
$4.28
52-Wochen-Spanne:
$2.71
$74.50
Mustang Bio Inc Stock (MBIO) Company Profile
Firmenname
Mustang Bio Inc
Sektor
Branche
Telefon
(781) 652-4500
Adresse
377 PLANTATION STREET, WORCESTER, NY
Vergleichen Sie MBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MBIO
Mustang Bio Inc
|
2.78 | 3.67M | 0 | -23.42M | -16.67M | -78.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 122.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 78.30B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.73B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.47B | 3.30B | -501.07M | 1.03B | -2.1146 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-18 | Eingeleitet | BTIG Research | Buy |
| 2020-10-02 | Eingeleitet | B. Riley FBR | Buy |
| 2019-11-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-06-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-12-21 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Mustang Bio Inc Aktie (MBIO) Neueste Nachrichten
Mustang Bio sets terms for $8M public offering - MSN
Mustang Bio Announces Pricing of $8 Million Public Offering - GlobeNewswire
Mustang Bio Announces Pricing of $8 Million Public Offering - Benzinga
Capital Raise Alert: Mustang Bio Secures Fresh $8M Funding Through Strategic Share & Warrant Offering - StockTitan
Mustang Bio says it needs additional funds to avoid bankruptcy - The Business Journals
Mustang Bio (NASDAQ:MBIO) Stock Quotes, Forecast and News Summary - Benzinga
Mustang Bio stock plunges to 52-week low of $4 - MSN
Mustang Bio (MBIO) Stock Price, News & Analysis - MarketBeat
Stock market today: VerifyMe -14.42%, PTL -13.23% among biggest losers in early trading - Business Upturn
Mustang Bio Inc. Appoints Michael J. Zelefsky as Director -June 13, 2017 at 04:02 pm EDT - Marketscreener.com
Mustang Bio, Inc. Announces Management Changes -April 24, 2017 at 08:00 am EDT - Marketscreener.com
Mustang Bio, Inc. Appoints Peter Carney as the Interim Chief Accounting Officer -December 12, 2023 at 06:23 am EST - Marketscreener.com
Mustang Bio, Inc. Terminates Exclusive License Agreement with Regents of the University of California - Marketscreener.com
UBriGene Biosciences Inc. completed the acquisition of Worcester manufacturing facility of Mustang Bio, Inc. - Marketscreener.com
Mustang Bio, Inc. Announces CFO Changes -November 15, 2024 at 04:50 pm EST - Marketscreener.com
Mustang Bio stock plunges to 52-week low of $0.13 By Investing.com - Investing.com Australia
Mustang Bio stock plunges to 52-week low of $0.13 - Investing.com
Mustang Bio Announces Reverse Stock Split - GlobeNewswire
Mustang Bio announces 1-for-50 reverse stock split By Investing.com - Investing.com Nigeria
Dow Gains Over 200 Points; Signet Jewelers Shares Plunge - Benzinga
Mustang Bio Lauds New Stock Split - Baystreet.ca
Mustang Bio announces 1-for-50 reverse stock split - Investing.com India
Mustang Bio secures shareholder nod for major stock issuance By Investing.com - Investing.com Nigeria
Mustang Bio secures shareholder nod for major stock issuance - Investing.com India
Carmell, Mustang Bio, Revelation Biosciences Dominate Retail Biotech Talk As 2025 Kicks Off - MSN
Fortress Biotech subsidiary's drug application accepted by FDA - Investing.com
Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews
Stock market news: Neumora Therapeutics down by 80.75% while N2OFF surged by 333.47% during mid day trading - Business Upturn
Wall Street Today: US stocks open higher after markets reopen post New Year; Tesla shares down 7% on low delivery data | Stock Market News - Mint
Mustang Bio files to sell 34.77M shares of common stock for holders - MSN
Mustang Bio Inc Still Hasn’t Convinced Analysts? - Stocks Register
Fortress Biotech subsidiary gains FDA approval for cSCC therapy - Investing.com
Likelihood of Approval and Phase Transition Success Rate ModelMB-108 in Recurrent Malignant Glioma - GlobalData
Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Malaysian Reserve
Mustang Bio faces delisting, appoints new interim CFO - Investing.com
Mustang Bio's Interim CFO Resigns After 10 Months - MarketWatch
Mustang Bio Faces Nasdaq Delisting and Leadership Changes - TipRanks
Mustang Bio, Inc. Announces CFO Changes - Marketscreener.com
ARMISTICE CAPITAL, LLC Acquires New Stake in Mustang Bio Inc - GuruFocus.com
Fortress Biotech Inc. (FBIOP) Quarterly 10-Q Report - Quartzy
Mustang Bio gets extension for Nasdaq compliance By Investing.com - Investing.com South Africa
Crude Oil Brent (F) (QAX25) Quote - The Globe and Mail
Mustang Bio gets extension for Nasdaq compliance - Investing.com
Mustang Bio Receives Positive Listing Determination from Nasdaq - The Manila Times
Finanzdaten der Mustang Bio Inc-Aktie (MBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):